Amneal Pharmaceuticals (AMRX) EBIT Growth (1y) (2018 - 2026)
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) EBIT Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.32 Bn | 38.67 Bn | 2.15 Bn | -150.77% |
| 2 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | -97.30% |
| 3 | Dr Reddys Laboratories | 9.74 Bn | 9.57 Bn | 396.53 Mn | -80.43% |
| 4 | Amneal Pharmaceuticals | 5.42 Bn | 5.29 Bn | 334.51 Mn | 16.52% |
| 5 | Bausch Health Companies | 2.29 Bn | 455.12 Mn | 2.10 Bn | 66.67% |
| 6 | Alvotech | 1.53 Bn | 1.39 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 191.25% |
| 8 | Amphastar Pharmaceuticals | 1.01 Bn | 721.54 Mn | 93.47 Mn | -5.82% |
| 9 | Fennec Pharmaceuticals | 396.58 Mn | 355.33 Mn | 17.15 Mn | 163.58% |
| 10 | RedHill Biopharma | 174.47 Mn | 174.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.52% |
| Mar 31, 2026 | 41.28% |
| Dec 31, 2025 | 47.81% |
| Sep 30, 2025 | -20.79% |
| Jun 30, 2025 | 16.66% |
| Mar 31, 2025 | 1,033.81% |
| Dec 31, 2024 | 434.02% |
| Sep 30, 2024 | 17.40% |
| Jun 30, 2024 | 19.21% |
| Mar 31, 2024 | -131.19% |
| Dec 31, 2023 | -60.61% |
| Sep 30, 2023 | 70.56% |
| Jun 30, 2023 | 140.32% |
| Mar 31, 2023 | 47.82% |
| Dec 31, 2022 | 222.43% |
| Sep 30, 2022 | 55.54% |
| Jun 30, 2022 | -395.92% |
| Mar 31, 2022 | -49.23% |
| Dec 31, 2021 | -44.62% |
| Sep 30, 2021 | 1,071.05% |